Jorrit Enserink

  • Group leader
  • +47 22 78 19 82
Jorrit is involved in all projects.

Helene Knævelsrud

  • Senior Scientist
  • +47 22 78 19 76

Helene joined the Enserink group in 2015 as a postdoc, bringing her own projects and expertise on fruit flies. In 2017 she obtained a 4 year researcher fellowship to identify the genetic framework underpinning MLL-rearranged leukemia using fruit flies as a model organism.

Nacho García

  • Senior Scientist
  • +47 22 78 19 68
Nacho joined the Enserink group on September 1, 2013. The aim of his studies is to identify new drugs to treat drug-resistant fungal infections in cancer patients.

Carmen Herrera

  • Postdoc
  • +47 22 78 19 75
Carmen joined the Enserink group as a post-doc on October 1, 2013. She is working on regulation of transcription using the model organism budding yeast.

Pilar Ayuda-Durán

  • Postdoc
  • +47 22 78 19 70

Joe Robertson

  • Postdoc
  • +47 22 78 19 69
Joe joined the Enserink group in February 2015. He works on the development of drugs that may provide new options for leukemia therapy.

Richard Crispin

  • Postdoc
  • +47 22 78 19 65
Richard joined the Enserink group in May 2017. He works on the discovery and development of novel small molecule for the potential application in the immunotherapeutic treatment of leukemia.

Sara Orellana Muñoz

  • Postdoc
  • +47 22 78 19 67

Sara is independently funded by the Fundación Alfonso Martín Escudero. She joined the Enserink group as a post-doc on August, 2017 and she is studying mechanisms of autophagy induction using the model organism budding yeast.

Robert Hanes

  • Postdoc
  • +47 22 78 18 46
Robert joined the Enserink group in October 2017. He is working on the identification and development of novel and personalized treatment strategies for leukemia through computational analysis of high-throughput data from drug sensitivity screens and various omics-based technologies.

Nathalia Chica

  • Postdoc
  • +47 22 78 19 66

Yngvar Fløisand

  • Head physician, Ph.D.
  • +47 23 07 24 62

Dagim Shiferaw Tadele

  • Ph.D. student M.Sc.
  • +47 22 78 19 58

Dagim's goal is to develop novel forms of cancer therapy.

Laure Piechaczyk

  • Ph.D. student M.Sc.
  • +47 22 78 19 58

Laure is from Lyon, France, and is working on a project aimed at identifying novel inhibitors of BCR-Abl, which causes CML.

Aurélie P. Nguéa

  • Ph.D. student M.Sc.
  • +47 22 78 19 72
Aurélie is a PhD student in the Enserink group since September 2013, and is working on regulation of transcription by post-translational modifications during cell stress.

Aram Nikolai Andersen

  • Ph.D. student
  • +47 22 78 19 72

Aram is combining mathematical modeling with various unsupervised and semi-supervised machine learning strategies to perform guided exploration in high-dimensional genetic perturbation screens; with primary focuses on characterizing fitness landscapes in cancer and system-control of autophagy dynamics in yeast.

Jeanne G. Corrales

  • Master Student
  • +47 22 78 19 73

Jeanne is working on the development of new antimycotics to treat drug-resistant fungal infections. She started her M.Sc. project with Nacho Garcia in 2018.

Desmond Mfua Abono

  • Master Student
  • +47 22 78 19 73

Desmond joined the Enserink group in April, 2018 for his Master project. The aim of his studies is to develop novel leukemia therapies based on personalized medicine.

Markéta Chlubnová

  • Master Student
  • +47 22 78 19 74

Markéta is working on the down-regulation of PDL1 in the development of small molecule immunotherapeutics and started her M.Sc. project with Richard Crispin in 2018.

Linda Håkensbakken Sønsterud

  • Master student
  • +47 22 78 19 68

Linda is working in the identification of new molecular targets to treat drug-resistant fungal infections in cancer patients

Andrea Moen Brodersen

  • Master Student
  • +47 22 78 19 68

 

Andrea is looking into improving systems for personalized medicine in lung cancer through the use of 3D cell cultures and machine learning strategies.

Ida Sundsøy Hallstensen

  • Master Student
  • +47 22 78 19 75

Ida is characterizing novel combination therapy that prevents resistance in patients after TKI treatments. She started her M.Sc. project with Carmen Herrera in 2019. She obtained her B.Sc. from University of Bergen. 

Femke Albertsboer

  • Internship
  • +47 22 78 19 73

Femke is working on the development of novel drugs for BCR-Abl-positive leukemia therapy.

Miriam Aarsund Larsen

  • Summer student
  • +47 22 78 19 76